COLUMBUS, Ga., Aug. 20, 2014 /PRNewswire/ -- Aflac
Incorporated (NYSE: AFL) announced today that Aflac Japan will
introduce a cancer insurance product called "New Cancer DAYS" on
September 22, 2014.
New Cancer DAYS provides enhanced coverage, including outpatient
treatments and multiple cancer occurrence benefits. At the same
time, premiums for this product have been lowered for most
ages.
In 1974, Aflac Japan pioneered supplemental cancer insurance.
This year marks Aflac's 40th anniversary in Japan.
ABOUT AFLAC
When a policyholder gets sick or hurt, Aflac pays cash benefits
fast. For nearly six decades, Aflac insurance policies have given
policyholders the opportunity to focus on recovery, not financial
stress. In the United States,
Aflac is the leading provider of voluntary insurance at the
worksite. In Japan, Aflac is the
number one life insurance company in terms of individual policies
in force. Aflac individual and group insurance products help
provide protection to more than 50 million people worldwide. For
eight consecutive years, Aflac has been recognized by Ethisphere
magazine as one of the World's Most Ethical Companies. In 2014,
FORTUNE magazine recognized Aflac as one of the 100 Best Companies
to Work For in America for the 16th consecutive year. Also, in
2014, FORTUNE magazine included Aflac on its list of Most Admired
Companies for the 13th time, ranking the company number one in the
life and health insurance category. Aflac Incorporated is a FORTUNE
500 company listed on the New York Stock Exchange under the symbol
AFL. To find out more about Aflac, visit aflac.com or
espanol.aflac.com.
FORWARD-LOOKING INFORMATION
The Private Securities Litigation Reform Act of 1995 provides
a "safe harbor" to encourage companies
to provide prospective information, so long as those informational
statements are identified as forward-looking and are accompanied by
meaningful cautionary statements identifying important factors that
could cause actual results to differ materially from those included
in the forward-looking statements. We desire to take advantage of
these provisions. This document contains cautionary
statements identifying important factors that could cause actual
results to differ materially from those projected herein, and in
any other statements made by company officials in
communications with the financial community and contained in
documents filed with the Securities and Exchange Commission
(SEC).
Forward-looking statements are not based on historical
information and relate to future operations, strategies, financial
results or other developments. Furthermore, forward-looking
information is subject to numerous assumptions, risks and
uncertainties. In particular, statements containing words such
as "expect," "anticipate,"
"believe," "goal,"
"objective," "may,"
"should," "estimate,"
"intends," "projects,"
"will," "assumes,"
"potential," "target" or similar
words as well as specific projections of future
results, generally qualify as forward-looking. Aflac
undertakes no obligation to update such forward-looking
statements. We caution readers that the following factors,
in addition to other factors mentioned from time to time, could
cause actual results to differ materially from those contemplated
by the forward-looking statements: difficult conditions in global
capital markets and the economy; governmental actions for the
purpose of stabilizing the financial markets; defaults and credit
downgrades of securities in our investment portfolio; exposure to
significant financial and capital markets risk; fluctuations in
foreign currency exchange rates; significant changes in investment
yield rates; credit and other risks associated with Aflac's
investment in perpetual securities; differing judgments applied to
investment valuations; significant valuation judgments in
determination of amount of impairments taken on our investments;
limited availability of acceptable yen-denominated investments;
concentration of our investments in any particular single-issuer or
sector concentration of business in Japan; decline in creditworthiness of other
financial institutions; deviations in actual experience from
pricing and reserving assumptions; subsidiaries' ability to pay
dividends to Aflac Incorporated; changes in law or regulation by
governmental authorities; ability to attract and retain qualified
sales associates and employees; decreases in our financial strength
or debt ratings; ability to continue to develop and implement
improvements in information technology systems; interruption in
telecommunication, information technology and other operational
systems, or a failure to maintain the security, confidentiality or
privacy of sensitive data residing on such systems; changes in U.S.
and/or Japanese accounting standards; failure to comply with
restrictions on patient privacy and information security; inability
to recognize tax benefits associated with capital loss
carryforwards; level and outcome of litigation; ability to
effectively manage key executive succession; catastrophic events
including, but not necessarily limited to, epidemics, pandemics,
tornadoes, hurricanes, earthquakes, tsunamis, acts of terrorism and
damage incidental to such events; ongoing changes in our industry;
events that damage our reputation; and failure of internal controls
or corporate governance policies and procedures.
Analyst and investor contact – Robin Y.
Wilkey, 706.596.3264 or 800.235.2667; FAX: 706.324.6330, or
rwilkey@aflac.com
Media contact – Catherine Blades,
706.596.3014; FAX: 706.320.2288 or cblades@aflac.com
Logo -
http://photos.prnewswire.com/prnh/20100423/CL92305LOGO
SOURCE Aflac Incorporated